Bicycle Therapeutics PLC (BCYC) income statement
BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3082% below fair value
$2.90−0.15 (-4.92%)
Close on Nov 20, 2026Market cap $203.27MP/E –Yield 0.00%
Bicycle Therapeutics PLC financial ratios
See a number that looks wrong?